BioCentury
ARTICLE | Company News

Ipsen, Merck KGaA sales and marketing update

December 20, 2010 8:00 AM UTC

Merck's EMD Serono Inc. affiliate received exclusive, Canadian rights from Ipsen's Tercica Inc. subsidiary to market Somatuline Autogel to treat acromegaly. Under the five-year deal, Ipsen will reta...